Back

Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology of ischaemic heart disease Noninvasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Sina Fathieh

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Unlocking the inflammatory 'code' in multivessel coronary disease: pathological network mediated by the PCSK9-NLRP3 axis and a novel microcirculatory dysfunction prediction model
Professor C. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Adipocytokines and risk of ischaemic events in acute coronary syndromes: an age-dependent relationship
Doctor F. Bruno (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Understanding the underpinning of hypertriglyceridemia as a risk factor for atherosclerosis
Doctor M. Ferreira (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Xanthosine alleviates myocardial ischemia-reperfusion injury through attenuation of cardiomyocyte ferroptosis
Doctor Y. Xu (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Pathology of medial calcification in coronary arteries
Doctor N. Nakamura (Isehara, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of ischaemic heart disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Examining the predictive value of plasma lysozyme for future all-cause mortality
thumbnail
Congress Presentation
Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors
thumbnail
Congress Presentation
Acute myocardial infarction in patients without standard modifiable risk factors - preliminary data on clinical and laboratory biomarkers from the beyond-smurfs study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources